Current status and progress in gene therapy for hemophilia B

[1] ANSON DS, 1987, MOL BIOL MED, V4, P11

[2] THE GENE STRUCTURE OF HUMAN ANTI-HEMOPHILIC FACTOR-IX [J]. EMBO JOURNAL, 1984, 3 (05) : 1053 - 1060

[3] EXPRESSION OF HUMAN FACTOR-IX IN RABBIT HEPATOCYTES BY RETROVIRUS-MEDIATED GENE-TRANSFER - POTENTIAL FOR GENE-THERAPY OF HEMOPHILIA-B [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) : 6141 - 6145

[4] PHENOTYPIC CORRECTION OF FACTOR-IX DEFICIENCY IN SKIN FIBROBLASTS OF HEMOPHILIC DOGS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5173 - 5177

[5] GENE-THERAPY VIA PRIMARY MYOBLASTS - LONG-TERM EXPRESSION OF FACTOR-IX PROTEIN FOLLOWING TRANSPLANTATION INVIVO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10892 - 10895

[6] DAI YF, 1992, SCI CHINA SER B, V35, P183

[7] CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) : 1401 - 1405

[8] GENE-THERAPY FOR HEMOPHILIA-B - HOST IMMUNOSUPPRESSION PROLONGS THE THERAPEUTIC EFFECT OF ADENOVIRUS-MEDIATED FACTOR-IX EXPRESSION [J]. HUMAN GENE THERAPY, 1995, 6 (08) : 1039 - 1044

[9] TOWARDS GENE-THERAPY FOR HEMOPHILIA-B USING PRIMARY HUMAN KERATINOCYTES [J]. NATURE GENETICS, 1993, 3 (02) : 180 - 183

[10] EXPRESSION OF BIOLOGICALLY-ACTIVE HUMAN FACTOR-IX IN HUMAN HEMATOPOIETIC-CELLS AFTER RETROVIRAL VECTOR-MEDIATED GENE TRANSDUCTION [J]. HUMAN GENE THERAPY, 1995, 6 (07) : 873 - 880

[1] ANSON DS, 1987, MOL BIOL MED, V4, P11

[2] THE GENE STRUCTURE OF HUMAN ANTI-HEMOPHILIC FACTOR-IX [J]. EMBO JOURNAL, 1984, 3 (05) : 1053 - 1060

[3] EXPRESSION OF HUMAN FACTOR-IX IN RABBIT HEPATOCYTES BY RETROVIRUS-MEDIATED GENE-TRANSFER - POTENTIAL FOR GENE-THERAPY OF HEMOPHILIA-B [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) : 6141 - 6145

[4] PHENOTYPIC CORRECTION OF FACTOR-IX DEFICIENCY IN SKIN FIBROBLASTS OF HEMOPHILIC DOGS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5173 - 5177

[5] GENE-THERAPY VIA PRIMARY MYOBLASTS - LONG-TERM EXPRESSION OF FACTOR-IX PROTEIN FOLLOWING TRANSPLANTATION INVIVO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10892 - 10895

[6] DAI YF, 1992, SCI CHINA SER B, V35, P183

[7] CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) : 1401 - 1405

[8] GENE-THERAPY FOR HEMOPHILIA-B - HOST IMMUNOSUPPRESSION PROLONGS THE THERAPEUTIC EFFECT OF ADENOVIRUS-MEDIATED FACTOR-IX EXPRESSION [J]. HUMAN GENE THERAPY, 1995, 6 (08) : 1039 - 1044

[9] TOWARDS GENE-THERAPY FOR HEMOPHILIA-B USING PRIMARY HUMAN KERATINOCYTES [J]. NATURE GENETICS, 1993, 3 (02) : 180 - 183

[10] EXPRESSION OF BIOLOGICALLY-ACTIVE HUMAN FACTOR-IX IN HUMAN HEMATOPOIETIC-CELLS AFTER RETROVIRAL VECTOR-MEDIATED GENE TRANSDUCTION [J]. HUMAN GENE THERAPY, 1995, 6 (07) : 873 - 880